Spark Therapeutics Reports First Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Spark Therapeutics (ONCE) Tops Q1 EPS by 2c
May 6, 2015 8:03 AM EDTSpark Therapeutics (NASDAQ: ONCE) reported Q1 EPS of ($0.56), $0.02 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.2 million.
As of March 31, 2015, Spark had cash and cash equivalents of $234.4 million, with 24.5 million shares... More
